A severe form of fatty liver disease called nonalcoholic steatohepatitis (NASH) is the leading cause of liver transplantation, but there are few treatment options and currently no medications. In a new study, Yale researchers ...
Sep 27, 2023
0
85
A team of researchers at the University of Massachusetts Amherst has shown that a single, small strand of microRNA, or miRNA, known as let-7, governs the ability of T-cells to recognize and remember tumor cells. This cellular ...
Sep 25, 2023
0
25
Northwestern Medicine investigators have discovered how the protein PD-1 controls essential metabolic processes in tumor cells to promote cancer growth in T-cell non-Hodgkin lymphomas (T-NHLs), according to a study published ...
Sep 21, 2023
0
26
Researchers from Ann & Robert H. Lurie Children's Hospital of Chicago and colleagues reported for the first time that a genetic biomarker may be able to help predict the severity of food allergy reactions.
Sep 20, 2023
0
1
Investigators have discovered a novel molecular pathway that promotes tumor growth in uterine fibroids that contain a specific genetic mutation, which could inform the development of new targeted therapies, according to a ...
Sep 20, 2023
0
3
Monash University Engineering researchers have successfully used "bioinks" containing living nerve cells (neurons) to print 3D nerve networks that can grow in the laboratory and transmit and respond to nerve signals. The ...
Sep 19, 2023
0
84
Survival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some blood cancers.
Sep 15, 2023
0
2
Shorter telomeres on the ends of white blood cell chromosomes may signal a heightened dementia risk, suggest the results of a large, long-term study published online in the journal General Psychiatry.
Sep 12, 2023
0
50
A leukemia test can help identify patients who are strong candidates for lifelong treatment free remission (TFR)—meaning they are effectively cured of the disease.
Sep 12, 2023
0
8
A new study published in Nature Genetics led by the Mead Group in the Radcliffe Department of Medicine has demonstrated a previously unknown effect of chronic inflammation on TP53-mutant hematopoietic stem cells.
Sep 8, 2023
0
253
